Skip to main content

Table 1 Subject demographics by treatment allocation

From: A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study

 

Panel A

Panel B

Panel C

 

Category

AVI-014 4 μg/kg

AVI-014 4 μg/kg

Filgrastim 4 μg/kg

AVI-014 8 μg/kg

Filgrastim 8 μg/kg

 

n

8

8

8

8

8

Race n (%)

White

4 (50.0)

2 (25.0)

3 (37.5)

3 (37.5)

1 (12.5)

 

Black

4 (50.0)

6 (75.0)

5 (62.5)

5 (62.5)

7 (87.5)

Gender n (%)

Male

7 (87.5)

5 (62.5)

4 (50.0)

5 (62.5)

8 (100.0)

 

Female

1 (12.5)

3 (37.5)

4 (50.0)

3 (37.5)

0 (0.0)

Age (years)

Mean (SD)

33.6 (7.8)

35.4 (6.6)

30.3 (5.1)

33.8 (5.7)

39.6 (7.3)

Weight (kg)

Mean (SD)

78.3 (10.4)

81.2 (12.1)

79.4 (7.9)

76.3 (6.1)

90.6 (11.9)

Height (cm)

Mean (SD)

177 (11)

175 (8)

170 (10)

173 (5)

181 (4)